Profiel
James C.
Lancaster Jr. has been Vice President of Commercial Operations for OREXIGEN Therapeutics, Inc. since August 2006.
Previously, he was a Marketing Consultant for Alkermes, Inc., G & S Research, Inc., Corcept Therapeutics, Inc., Neuronetics, Inc. and Eli Lilly and Company from March 2004 to August 2006.
Mr. Lancaster received a BS degree in Pharmacy from the University of Tennessee.
Eerdere bekende functies van James C. Lancaster
Bedrijven | Functie | Einde |
---|---|---|
OREXIGEN THERAPEUTICS, INC. | Corporate Officer/Principal | 10-03-2008 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01-02-2003 |
Opleiding van James C. Lancaster
University of Tennessee | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Orexigen Therapeutics, Inc.
Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |